Moreover, AFP and HSA exhibited numerous similarities, such as overall conformation resemblances and multiple high-affinity FA binding sites, which enabled AFP to possess potential as a drug delivery system that holds great promise for the treatment of certain cancers (e.g., liver cancer). The gene discussed is ALB; the disease is liver cancer.